Heat Biologics (HTBX) Takes Upward Bounce; CLARCOR (CLC) Posts Upbeat Earnings


Shares of Heat Biologics, Inc. (Nasdaq:HTBX) soared more than 239% to touch the $2.51 mark in early trade Thursday after the company disclosed in a regulatory filing with the SEC that it will make several presentations for investors during the next few weeks to talk about the current focus of its clinical programs

HTBX stock is trading at $1.43, up $0.69 (or +93.27%), and 3,313,677 shares of the company exchanged hands so far, representing a large increase in activity versus its average volume (3m) of 91,515

Heat Biologics, an immuno-oncology company, has 8.42M Shares Outstanding and HTBX stock 52-week range is between $0.72 and $8.65 per share



The price of CLARCOR Inc. (NYSE:CLC) stock climbed on Thursday’s trading session as the company delivered stronger-than-expected quartely numbers in its financial results

For its first quarter fiscal 2016, CLARCOR posted revenues of $316.3 million and non-GAAP net income of $21.7 million or $0.44 per diluted share, exceeding the Capital IQ Consensus estimate of $0.40 earnings per share on revenues of $310.87 million for the period

CLC stock is exchaning hands at $56.52, up $5.17 (or +10.07%), and 782,694 of its shares were traded so far

CLARCOR, a diversified marketer and manufacturer of mobile, industrial and environmental filtration products, has 48.75M Shares Outstanding and CLC stock one-year range is from $44.13 to $66.99 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/